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Prostaglandin D2 synthase induces apoptosis in pig kidney let aggregation, inhibit nitric oxide release, induce vaso-
LLC-PK1 cells. dilation, and act as an allergic and inflammatory lipid
Background. Prostaglandin D2 synthase (PGD2S), a unique mediator [1], is the precursor of 15-deoxy 12,14 prosta-member of the lipocalin family, is found at elevated levels in
glandin J2 (15-dPGJ2), a natural peroxisome proliferator-the serum of patients with renal impairment and has recently
activated receptor- (PPAR) ligand known to causebeen implicated as a new biochemical marker of renal insuffi-
ciency. The aim of this study was to investigate the apoptotic apoptosis [2]. Depending on the glycosylation status,
effects of PGD2S on a pig kidney epithelial cell line (LLC-PK1) PGD2S migrates anywhere from 20 to 29 kD on sodiumand to investigate the effects of prostaglandins and growth dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-factors on this process.
PAGE). The enzyme, originally discovered as a majorMethods. Apoptosis was detected by terminal deoxynu-
cleotidyl transferase (TdT)-mediated dUTP nick end-labeling protein of human cerebrospinal fluid, has a dual function
(TUNEL), annexin V staining, and electron microscopy. since it also acts as a lipophilic ligand-binding protein,
Results. A four- to fivefold increase in apoptosis was ob- binding and transporting retinoids, thyroids and bile pig-
served in PGD2S-treated cells as compared with controls and the ments [1]. Recently, PGD2S levels were found to beapoptosis appeared to act via caspase-3. A cyclooxygenase-2
elevated in the serum of patients with renal impairment,inhibitor, anti-PGD2S antibody, and selenium all significantly
inhibited the apoptosis induced by PGD2S; however, none had and the protein has even been suggested as a new bio-
any effect on the apoptosis induced by the known apoptotic chemical marker of renal insufficiency [3].
inducer camptothecin. Furthermore, prostaglandins E1 and E2, Apoptotic cell death has been observed in the courseknown to induce mitogen-activated protein (MAP) kinase
of renal injury and in clinical kidney diseases such asphosphorylation and exhibit cytoprotective effects, both inhib-
glomerulonephritis, acute and chronic kidney failure, dia-ited PGD2S-induced apoptosis, while prostaglandin H2 had no
significant effect. Growth factors such as insulin, insulin-like betic nephropathy, and polycystic kidney disease [4]. Apo-
growth factor-1, and platelet-derived growth factor also de- ptosis triggered by ischemia, exogenous toxins, or endog-
creased PGD2S-induced apoptosis. In addition, PGD2S isolated enous factors may be the initial offense that leads tofrom human serum seemed slightly more effective at inducing
renal disease [5]. Beneficial apoptotic effects also haveapoptosis than recombinantly expressed protein.
Conclusions. We report on the induction of apoptosis by been observed, as in the case of tissue remodeling and
PGD2S in LLC-PK1 pig kidney epithelial cells, and speculate recovery after renal injury. Many renal diseases are char-
that the accumulation of PGD2S in the serum of kidney failure acterized by monocyte infiltration, and the clearance ofpatients may further exacerbate renal problems and is most
these cells by apoptosis is essential to the resolution oflikely regulated by other prostaglandins and growth factors.
renal inflammation. Several factors have been shown to
alter the balance between survival and apoptosis in the
Lipocalin-type prostaglandin D2 synthase (PGD2S), renal microenvironment. Survival factors include insulin-
also known as -trace protein, is responsible for the con- like growth factor (IGF-1), epidermal growth factor
version of prostaglandin H2 (PGH2) into prostaglandin (EGF), and platelet-derived growth factor (PDGF),
D2 (PGD2). PGD2, reported to induce sleep, inhibit plate- which have been shown to inhibit apoptosis in renal
fibroblasts [6, 7].
Recent evidence suggests that arachidonic acid metab-Key words: -trace protein, lipophilic ligand-binding protein, cell
death, renal insufficiency, peroxisome proliferator-activated receptors. olites, namely prostaglandins, are involved in regulating
cell proliferation. The prostaglandin A and J series ex-Received for publication March 13, 2001
hibit growth inhibitory and antitumor effects [8], whileand in revised form May 15, 2001
Accepted for publication June 5, 2001 prostaglandin E2 (PGE2), a major arachidonic acid me-
tabolite of the mammalian kidney, has been shown to 2001 by the International Society of Nephrology
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modulate renal hemodynamics, metabolism, water and from R&D Systems (Minneapolis, MN, USA) was used
according to the manufacturer’s directions. Briefly, LLC-ion transport, and sympathetic nerve activity [9, 10]. Miso-
prostol, a stable PGE1 analogue, is cytoprotective against PK1 cells were plated on chamber slides as described
previously and were exposed for two hours to the experi-renal ischemic-induced injury in male Sprague-Dawley
rats [11]. Prostaglandins also have been shown to protect mental and control samples, washed twice with cold phos-
phate-buffered saline (PBS), and then covered with fluo-the kidney from a variety of toxins, although an exact
cellular mechanism remains unknown [12]. Several up- rescein-conjugated annexin V and propidium iodide. The
cells were incubated for 15 minutes at room temperaturestream factors of prostaglandin synthesis have been impli-
cated in the regulation of cellular apoptosis. For example, in the dark, and cell staining was visualized with an
epifluorescence microscope (Nikon Optiphot, Melville,inhibition of 85 kD phospholipase A2 (PLA2), the enzyme
responsible for hydrolyzing membrane phospholipids into NY, USA) at 490 nm for annexin and 570 nm for propid-
ium iodide. A total of at least 1000 cells were countedarachidonic acid, resulted in a dose-dependent inhibition
of cellular proliferation [13]. Other prostaglandins such per condition and the apoptotic index  SEM was calcu-
lated and converted into fold increase over basal. Elec-as 15-dPGJ2, which is quickly formed from PGD2, are
known to inhibit basic fibroblast growth factor (bFGF)- tron micrograph of LLC-PK1 cells plated at 1  103 cells
per 35-mm Falcon Petri dish (Becton Dickinson, Frank-induced DNA synthesis and inhibit PDGF-directed mi-
gration [14]. lin Lakes, NJ, USA), exposed to test reagent and fixed
with 2.5% glutaraldehyde in 0.1 mol/L sodium cacodyl-Since PGD2S levels are elevated in patients with renal
failure, our objective was to examine the effect of PGD2S ate, pH 7.2, for one hour at 4C, was used as additional
support for apoptosis versus necrosis. The cells were post-on LLC-PK1 cells. In addition, the effects of other pros-
taglandins and growth factors on PGD2S-induced apo- fixed in 1% buffered osmium tetroxide, dehydrated in a
graded series of ethanol, and embedded in LX112 (Laddptosis also were determined.
Research Industries, Burlington, VT, USA). En face thin
sections were stained with uranyl acetate and lead citrate
METHODS
and examined on a Zeiss EM10 transmission electron
Cell culture microscope (Carl Zeiss, Inc., Thornwood, NY, USA). Apo-
ptotic index was determined from three blocks represent-The pig kidney epithelial cell line LLC-PK1, a kind
gift from Dr. Julia Lever (University of Texas, Houston, ing different areas from each sample and examined for
morphologically apoptotic cells, that is, condensed, black-TX, USA), was maintained in Dulbecco’s modified Ea-
gle’s medium (DMEM)/F12 supplemented with 10% fe- ened nuclei. A total of at least 200 cells were counted
per condition, and the apoptotic index SEM was deter-tal calf serum, 7.5% sodium bicarbonate, 15 mmol/L
HEPES, 200 mmol/L l-glutamate, 50 U/mL penicillin, mined.
and 50 g/mL streptomycin (Life Technologies, Gaith-
PGD2S protein overexpression and purificationersburg, MD, USA) at 37C in 5% CO2. For terminal
deoxynucleotidyl transferase-mediated dUTP nick end- To obtain the PGD2S for our studies, the protein was
overexpressed and purified from Escherichia coli. Thelabeling (TUNEL) assay, the cells were plated at a den-
sity of 4.0 104 cells/cm2 onto Nunc Permanox eight-well cDNA for human PGD2S was obtained from the ATCC
(#2519499), verified by sequence analysis (data not shown),chamber slides (Rochester, NY, USA). For experiments
involving growth factors, the cells were serum-starved and inserted in-frame into the BamHI site of vector
pRSETA by standard techniques, resulting in plasmidfor 24 hours prior to experimental treatments in the same
medium without fetal calf serum. pRSETA/PGDS. This vector is part of the XpressJ protein
expression system (Invitrogen, Carlsbad, CA, USA), which
Detection of apoptosis is designed for high-level prokaryotic expression controlled
by a T7 promoter. Expression of the inserted gene is viaNuclear fragmentation consistent with apoptosis was
determined primarily by the TUNEL assay as previously the induction of T7 polymerase with 2.0 mmol/L isopropyl-
-thio-D-galactopyranoside (IPTG) in BL21(DE3) E. colidescribed in Maesaka et al [15] using the ApopDetek
Cell Death Assay Kit (Enzo, Farmingdale, NY, USA). after cells reach mid-log phase. Purification of the protein
was facilitated by the polyhistidine tag at the amino ter-Cells were scored as TUNEL positive if they appeared as
condensed cells with dark nuclei. In all assays, the apoptotic minus of the PGD2S fusion protein and the ProBondJ
resin included in the kit. Finally, the polyhistidine wasindex was calculated as the percentage of TUNEL-posi-
tive cells and represented at least 1000 cells counted, removed via enterokinase and the resulting 21 kD pro-
tein was confirmed by Western analysis (data not shown),and was expressed as the mean  SEM. In addition
to the TUNEL assay described earlier in this article, using an antibody to PGD2S kindly provided by D.C.
Cheng (Protein Chemistry Core Laboratory, Rockefellerapoptosis was confirmed by annexin V staining and elec-
tron microscopy. The annexin V apoptosis detection kit University, New York, NY, USA).
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Fig. 1. Dose-response of prostaglandin D2 synthase (PGD2S)-induced
Fig. 2. Time course of PGD2S-induced apoptosis. LLC-PK1 cells atapoptosis. LLC-PK1 cells at 75% confluence were treated with PGD2S
75% confluence were treated with PGD2S (50 g/mL) for 0 to 24 hours.(0 to 400 g/mL) for 24 hours. The TUNEL assay was used to quantitate
Apoptosis was quantified using the TUNEL assay as described in thethe apoptotic index. Results are expressed as the mean  SEM of four
Methods section. Results are the mean  SEM of four independentindependent experiments each performed in duplicate and converted
experiments each performed in duplicate and converted into fold in-into fold increase over basal values.
crease over basal values.
Statistics
An unpaired Student t test was used to compare one
set of experiments with another and P 0.05 was deemed
significant.
RESULTS
Effect of PGD2S on LLC-PK1 apoptotic activity
The kinetics of PGD2S incubation and apoptotic in-
duction were measured in LLC-PK1 cells at 75% con-
fluence by the TUNEL assay. When the cells were incu-
bated with PGD2S at concentrations between 0 and 400
g/mL for 24 hours, the apoptotic index was linear up
to 200 g/mL, after which the apoptotic index reached Fig. 3. Confirmation of apoptosis with annexin V staining. LLC-PK1
cells at 75% confluence were cultured as described in the Methodssaturation (Fig. 1). Using a fixed concentration of 50
section and either 50 g/mL PGD2S or 10 mol/L camptothecin wasg/mL PGD2S, a time course of apoptotic induction was incubated with the cells for 16 hours. Cells were fixed and stained with
determined. As shown in Figure 2, apoptosis was fairly annexin V () or propidium iodide ( ) as described in the Methods
section. Results are the mean SEM of three independent experimentslinear over the 24-hour period studied. We therefore
each performed in duplicate.decided to use PGD2S at a concentration of 50 g/mL
for 16 hours as our standard apoptotic induction proto-
col. This concentration was both convenient and close
to the approximate physiological concentration observed g/mL) for 16 hours, the positive staining pattern of
in renal dialysis patients. annexin V was elevated sixfold when compared with con-
trols and matched that of the known apoptotic inducer
Confirmation of PGD2S-induced apoptosis camptothecin (Fig. 3). Propidium iodide, which stains
To confirm apoptotic cell death versus necrosis, both nuclei and represents necrosis, was relatively constant
the annexin V staining assay and electron microscopy of for all treatments (Fig. 3). Characteristics of apoptotic
PGD2S-induced cells were used. The annexin V assay cells include cell shrinkage and condensed nuclei. Figure
exploits the fact that in apoptotic cells the phosphatidyl 4 shows representative electron micrographs of LLC-
serine, usually localized on the interior membrane, is PK1 cells incubated in the absence or presence of PGD2S.
inverted to the outer membrane where it can bind the As seen in Figure 4A, the control cells have round, clearly
defined nuclei. However, when PGD2S (50 g/mL) isannexin V stain. When cells were exposed to PGD2S (50
Maesaka et al: PGD2S induces apoptosis in LLC-PK1 1695
Fig. 4. Confirmation of apoptosis with electron microscopy. LLC-PK1
cells at 75% confluence were cultured as described in methods and
exposed for 16 hours to either (A) buffer alone or (B) 50 g/mL PGD2S.
The electron micrographs were prepared as described in the Methods
section. The arrows indicate nuclear membranes and the bar in each Fig. 6. Inhibition of PGD2S-induced apoptosis with selenium. LLC-
micrograph represents 1 m. PK1 cells at 75% confluence were cultured as described in the Methods
section and pre-incubated with 500 nmol/L sodium selenite for 15 min-
utes prior to incubation with 50 g/mL PGD2S. Apoptotic index was
determined by TUNEL assay as described in the Methods and the
Results sections expressed as mean  SEM of four experiments per-
formed in duplicate and converted into fold increase over basal. *P 
0.05 versus control.
specific inhibitor, NS398, was added and returned the apo-
ptotic values back to control levels, while having no effect
on camptothecin-induced apoptosis (Fig. 5).
Inhibition of PGD2S-induced apoptosis
Selenium compounds are known inhibitors of PGD2S
enzymatic activity when preincubated with dithiothreitol
[16]. We therefore attempted to determine whether sele-
nium would affect the apoptosis induced by PGD2S.
Fig. 5. Inhibition of PGD2S-induced apoptosis with anti-PGD2S Ab When LLC-PK1 cells were incubated with 50 g/mL
and NS398. LLC-PK1 cells at 75% confluence were cultured as de- PGD2S for 16 hours in the presence of 50 nmol/L sele-scribed in the Methods section and preincubated with either 10 mol/L
nium, apoptosis was reduced to background levels (Fig.NS398 or 40 g anti-PGD2S Ab for 15 minutes prior to incubation with
either 50 g/mL PGD2S or 10 mol/L camptothecin. Symbols are: () 6). Selenium alone had no effect on the apoptotic level.
untreated; ( ) NS398; ( ) anti-PGD2S antibody. The apoptotic index Activation of caspase activity is a characteristic featurewas determined by TUNEL assay as described in the Methods and the
of apoptosis. The caspase-3 inhibitor N-benzylcarbonyl-Results sections, and was expressed as mean SEM of four experiments
performed in duplicate and converted into fold increase over basal Asp-Glu-Val-Asp-fluoromethyl ketone (Z-DEVD) in-
values. *P  0.05 versus control; **P  0.05 versus untreated. hibited PGD2S-induced apoptosis, whereas the control
peptide, N-benzyloxycarbonyl-Phe-Ala-fluoromethyl ke-
tone (Z-FA), had no effect (Fig. 7).
Since several growth factors have been shown to actadded to the cells for 16 hours, the nuclei display apo-
as survival factors in renal epithelium [17], and certainptotic characteristics such as cell shrinkage and condensed
prostaglandins have also been deemed cytoprotectivenuclei (Fig. 4B). The apoptotic index was determined by
[18], we sought to determine the effects of these factorselectron microscopy and was within 10% of the apoptotic
on PGD2S-induced apoptosis. When LLC-PK1 cells wereindex calculated using the TUNEL assay (data not shown).
serum starved for 24 hours in the presence of PGD2S, theFinally, PGD2S antibody was used to inhibit the PGD2S-
apoptotic activity was increased threefold over controlinduced apoptosis and to add further support to our con-
serum-starved cells (Fig. 8). The increase in PGD2S-tention that PGD2S was indeed the agent responsible for
induced apoptosis was inhibited with the inclusion ofinducing apoptosis in the LLC-PK1 cells. As shown in
either IGF-1, insulin, or PDGF in the medium (Fig. 8).Figure 5, anti-PGD2S antibody was able to inhibit the apo-
The effect of other arachidonic acid-derived prosta-ptosis induced by PGD2S but had no effect on the camp-
tothecin-induced apoptosis. The cyclooxygenase (COX)-2 glandins on PGD2S-induced apoptosis also was exam-
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Fig. 7. Effect of caspase-3 inhibitors on PGD2S-induced apoptosis. LLC-
PK1 cells at 75% confluence were exposed to either PGD2S (50 g/mL)
for 16 hours in the presence of either 50 mol/L N-benzylcarbonyl-
Asp-Glu-Asp-fluoromethyl ketone (Z-DEVD), 20 mol/L N-benzyloxy-
Fig. 9. Effect of other prostaglandins on PGD2S-induced apoptosis.carbonyl-Phe-Ala-fluoromethyl ketone (Z-FA) or dimethyl sulfoxide
LLC-PK1 cells at 75% confluence were exposed for 16 hours to 50 g/mL(DMSO) (control) and the apoptotic index measured by TUNEL assay.
PGD2S alone or in combination with 60g/mL PGH2, 100 nmol/L PGE1,Apoptotic values are the means  SEM of at least six different experi-
100 mol/L PGE2, 100 nmol/L PGF2	. Apoptotic values, determined byments performed in duplicate and converted into fold increase over
TUNEL assay, are the means  SEM of at least four different experi-basal. *P  0.05 versus control.
ments performed in duplicate and converted into fold increase over
basal values. *P  0.05 versus PGD2S alone.
Fig. 8. Effect of growth factors on PGD2S-induced apoptosis. LLC-
PK1 cells at 75% confluence were serum-starved for 24 hours in medium
Fig. 10. Effect of PGD2S enzymatic products on apoptosis. LLC-PK1without fetal bovine serum. Cells were then exposed to 20 ng/mL insulin-
cells at 75% confluence were exposed for 2 hours to 15 g/mL PGD2like growth factor-l (IGF-1), 10 nmol/L insulin, or 2.0 ng/mL platelet-
or 18 g/mL 15-dPGJ2 and the apoptotic values determined by TUNELderived growth factor (PDGF) for 30 minutes prior to exposure of 50
assay. Values are the means  SEM of at least three different experi-
g/mL PGD2S and the apoptotic index calculated by TUNEL assay. ments performed in duplicate and converted into fold increase overSymbols are: () control; () PGD2S. Results are the mean  SEM basal.of three different experiments each performed in duplicate and con-
verted into fold increase over basal values. *P  0.05 versus control.
enzymatic products, PGD2 and 15-dPGJ2, were exam-
ined. As demonstrated in Figure 10, both PGD2 and 15-ined. While the addition of PGH2 had no effect on
dPGJ2 induced a three- to fourfold increase in LLC-PK1PGD2S-induced apoptosis, preincubation with either
apoptosis after only a two-hour incubation.PGE1 or PGE2 fully inhibited the apoptosis induced by
PGD2S (Fig. 9).
PGD2S isoforms induce apoptosis
PGD2S enzymatic products induce apoptosis While it was clear that our recombinant PGD2S, iso-
lated from E. coli, induced apoptosis, we decided to studyTo elucidate further a possible mechanism of action
for PGD2S-induced apoptosis, the effects of two PGD2S the effect on apoptosis of PGD2S isolated from different
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and 15-dPGJ2 induced a three- to fourfold increase in
apoptosis after only two hours of exposure suggests the
former (Fig. 10). Since PGD2S is located at a vital branch
point of PGH2 distribution, the elevated serum PGD2S
levels detected in patients with kidney failure may alter
the balance of PGH2 derivatives from the cytoprotective
prostaglandins such as PGE1 and PGE2 into PGD2 and
subsequently PGJ2 and its derivatives. These PGJ2 deriv-
atives are natural ligands of peroxisome proliferator-
activated receptors and have been shown to induce apo-
ptosis in certain cell lines [2]. It is worth noting that
homozygous prostaglandin endoperoxide H synthase-2
knockout mice, deficient in COX-2, have been generated
and appear to develop severe nephropathy [21]. Increas-
ing the level of PGD2S may deplete PGH2 levels and
Fig. 11. Effect of PGD2S isoforms on apoptosis. LLC-PK1 cells at 75% result in a similar consequence. Alternatively, the pro-
confluence were treated with 0 to 200 g/mL PGD2S isolated from tein may act via a receptor or as a facilitator for thehuman serum () or Trichoplusia ni. () for 24 hours. The TUNEL
internalization of some other compound, for example,assay was used to quantitate the apoptotic index. Results are expressed
as the mean of one experiment performed in duplicate. retinoids, which are known to bind to PGD2S [1].
The influence of growth factors and certain prostaglan-
dins on renal cell survival has been examined and is
dependent on cell type [11, 12, 18, 22, 23]. PGE1 andsources. PGD2S derived from human serum and recom-
PGE2 have been shown to protect renal epithelial cellsbinantly expressed in Trichoplusia ni. [19, 20], kindly
from hypoxic injury [11]. Our study found PGE1 andprovided by Dr. Harald Conradt, (German Research Cen-
PGE2 to behave in a similar cytoprotective manner, de-ter for Biotechnology GBF, Braunschweig, Germany),
creasing the apoptosis induced by PGD2S, while PGH2were tested for apoptotic activity by TUNEL assay. PGD2S
had no effect (Fig. 9). Furthermore, IGF-1, EGF, andisolated from human serum at 100 g/mL had a sixfold
PDGF all acted as survival factors protecting LLC-PK1increased apoptotic induction when compared with the
cells from PGD2S-induced apoptosis (Fig. 8). The protec-control, and a three- to fourfold increase in apoptotic
tion from apoptosis by PDGF was not anticipated sinceinduction over the recombinant PGD2S, which was iso-
PDGF failed to protect human and rat mesangial cellslated from T. ni. (Fig. 11) or E. coli (Fig. 1), respectively.
from apoptosis induced by serum-starvation and DNA
damage [24]. The interplay of growth factors, as well as
DISCUSSION other prostaglandins, undoubtedly has a role in regulat-
ing PGD2S-induced apoptosis, but it is clear that PGD2SThe present study demonstrates a dose- and time-
dependent apoptotic induction in LLC-PK1 cells by re- has a definite role in maintaining renal cell homeostasis.
The difference in apoptotic induction observed be-combinant PGD2S, as well as native protein isolated from
human serum, using the TUNEL assay. We were confi- tween the recombinant PGD2S and the human protein
isolated from serum suggests some sort of regulationdent that the cells were undergoing apoptosis for several
reasons in addition to the positive TUNEL assay. The by glycosylation since the two proteins differ by this
modification. It is likely, given the distribution of PGD2Sannexin V staining pattern, the physical characteristics ob-
served by electron microscopy, and the inhibition of apo- throughout the body, that its role as an apoptotic inducer
must be under some sort of regulation, which most likelyptosis observed with the caspase-3 inhibitor, Z-DEVD,
all supported the notion of apoptotic cell death versus is a type of glycosylation of this protein. We are currently
investigating the exact mechanism by which PGD2S in-necrosis. The effect also was demonstrated in the well-
characterized and immortalized human proximal tubular duces apoptosis and the regulation by glycosylation.
It is tempting to envision other apoptotic-inducingcell line, HK2 (data not shown).
The mechanism of PGD2S’s apoptotic action is uncer- functions for PGD2S. Throughout embryogenesis, the
PGD2S protein expression pattern is highly specific totain but quite possibly involves its enzymatic activity.
The fact that NS398, a COX-2–specific inhibitor (Fig. 5), blood-tissue barriers such as blood-cerebrospinal, blood-
testis, blood-aqueous humor, and blood-retina. PGD2Sand selenium, an inhibitor of PGD2S enzymatic activity
(Fig. 6), both inhibited the PGD2S-induced apoptosis may play a role in embryogenesis as an inducer of cellular
apoptosis during tissue differentiation. The elevatedsuggests that the protein is inducing apoptosis via the
production of its downstream enzymatic products or by PGD2S levels found in seminal fluid may help control
the relatively rapid turnover rate of sperm cells. Further-the depletion of its substrate. The fact that both PGD2
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7. Chevalier RL, Goyal S, Wolstenholme JT, Thronhill BA: Ob-more, PGD2S levels are altered in the cerebrospinal fluid structive nephropathy in the neonatal rat is attenuated by epider-
of patients with central nervous diseases, which again mal growth factor. Kidney Int 54:38–47, 1998
8. Fukushima M, Kato T, Narumiya S, et al: Prostaglandin A andsuggests a possible apoptotic role for this protein. Our
J: Antitumor and antiviral prostaglandins. Adv Prostaglandinunpublished data from PC12 and N-TERA-2 cells sug-
Thromboxane Leukotrienes Res 19:415–418, 1989
gest a similar apoptotic function for PGD2S in neuronal 9. Herbert RL, Jacobson HR, Fredin D, Breyer MD: Evidence
that separate PGE2 receptors modulate water and sodium transportcells, and its role in some of these processes is currently
in rabbit cortical collecting duct. Am J Physiol 265:F643–F650,under investigation.
1993
Our current study introduces a novel role for PGD2S 10. Moore PK: Prostanoids and the kidney, in Prostanoids: Pharmaco-
logical, Physiological and Clinical Relevance, edited by Moore PK,as an apoptotic inducer. We speculate that the accumula-
New York, Cambridge University Press, 1985, pp.173–179tion of PGD2S in the serum of kidney failure patients, 11. Paller MS, Manivel JC: Prostaglandins protect kidneys against
a chronic complication of kidney failure resulting from ischemic and toxic injury by a cellular effect. Kidney Int 42:1345–
1354, 1992decreased kidney function, may exacerbate renal prob-
12. Weber TJ, Monks TJ, Lau SS: PGE2-mediated cytoprotection inlems by the apoptosis of intrinsic renal cells, as well as
renal epithelial cells: Evidence for a pharmacologically distinct
the infiltrating leukocytes associated with renal disease, receptor. Am J Physiol 273(4 Pt 2):F507–F515, 1997
13. Anderson KM, Roshak A, Winkler JD, et al: Cytosolic 85-kDaand contribute to the pathogenesis of renal disease. Fur-
phospholipase A2-mediated release of arachidonic acid is criticalther investigation should help clarify the exact role of
for proliferation of vascular smooth muscle cells. J Biol Chem
PGD2S in renal disease. 272:30504–30511, 1997
14. Law RE, Goetze S, Xi XP, et al: Expression and function of
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